With the last three months of 2025 approaching, investors seeking new opportunities to end the year may consider penny stocks.
The market currently offers several lucrative options backed by strong fundamentals. In this context, Finbold turned to OpenAI’s ChatGPT model, which identified two penny stocks worth buying in Q4 2025.
ModivCare (NASDAQ: MODV)
The first pick is ModivCare (NASDAQ: MODV), operating in the healthcare services sector, which is navigating a significant restructuring process following a Chapter 11 bankruptcy filing.
The company is working to reduce debt and secure capital to stabilize operations, with some insider activity suggesting confidence in its turnaround potential.
Notably, the restructuring is backed by the majority of its lenders, with over 90% of First Lien and 70% of Second Lien Lenders signing a Restructuring Support Agreement. ModivCare will receive $100 million in debtor-in-possession financing, maintain over $100 million in liquidity, and reduce debt by $1.1 billion.
According to the company, the move will create a stronger, sustainable organization ready to grow and continue providing non-emergency medical transportation, personal care, and remote patient monitoring services.
While it faces challenges, including delisting and operational hurdles, analysts are monitoring whether these efforts could lead to a recovery or make ModivCare an acquisition target.
By press time, MODVQ stock was priced at $0.18, having corrected almost 100% year to date.
Ceragon Networks (NASDAQ: CRNT)
For the second choice, ChatGPT recommended Ceragon Networks (NASDAQ: CRNT), a telecommunications equipment company.
The stock has seen bearish momentum for much of 2025, dropping almost 50% year to date to trade at $2.37 at the last close.
The model noted that the company’s potential lies in its steady revenue generation and active participation in projects modernizing communications networks.
In the most recent quarter, statutory profit was reduced by $5.3 million due to unusual items, which are generally one-off and unlikely to recur, suggesting potential for profit growth if these items do not repeat.
At the same time, Ceragon has faced challenges in India due to carrier financing and logistics issues, while North America showed strong performance. Management remains focused on technology leadership, validated by a recent U.S. tier 1 win expected to ramp in 2026.
However, the firm continues to contend with profitability issues and competitive pressures from larger industry players, which could impact its ability to scale and sustain long-term growth.
Featured image via Shutterstock
